The freedom to explore
Whether you need complex DNA for mRNA, protein engineering, CGT or synbio
Our new ssDNA Oligos can help you push the boundaries of your research
Where could your research take you?
Order ssDNAThe freedom to explore
Whether you need complex DNA for mRNA, protein engineering, CGT or synbio
Our new ssDNA Oligos can help you push the boundaries of your research
Where could your research take you?
Order ssDNASYNTAX System:
The world’s first DNA printer powered by EDS
Powered by Enzymatic DNA Synthesis (EDS), the SYNTAX System puts you in control of DNA oligo production. Create custom DNA oligos that are ready to use the same day you need them.
DISCOVER THE POWER OF SYNTAX
Accessible
- On-demand, in-house oligo production
- No specialized training or skills required
- Simple and safe
Convenient, Fast, and Flexible
- Update or modify designs in minutes with plug-and-play workflows
- Produce variable DNA oligo lengths and batch sizes
- Micromolar scale supports single use and rapid iteration
Full Control from Sequence to Application
- Improved control over sequence information and security
- Freedom from delays or backorders
- Accelerate innovation and reduce hidden project costs

FEATURED COLLABORATION
See how our EDS technology is being leveraged to deploy vaccines as part of DARPA NOW.
Learn More ▶

FEATURED APPLICATION
See how primers produced using our EDS technology were used for sequencing and analysis of SARS-CoV-2.
Learn More ▶
See how we’re revolutionizing biological research

PRESS RELEASE
Pushing mRNA vaccine development timelines to new speeds
6 February 2025; OSLO; PARIS: Scientists in Paris are set to advance new technology that could streamline the production of … Learn More ▶

MEDIA COVERAGE
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, …
CAIRO, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a … Learn More ▶

The technology
Enzymatic DNA Synthesis (EDS) offers significant advantages in accessibility and convenience, transforming the pace of and control over custom DNA oligo production, with reduced environmental impact over traditional outsourced, chemical-based synthesis.
LEARN MORE ABOUT EDS
Applications in molecular biology, genomics, and more
See how industry leaders are using our SYNTAX Platform to power discoveries in genomics, personalized medicine, and beyond.
VIEW APPLICATIONS
